Evidence map›Paper›PMID 37443714›Full record

ArticleCells2023

Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma.

Sara Huber, Theresia Fitzner, René G Feichtinger, Sarah Hochmann, Theo Kraus, Karl Sotlar, Barbara Kofler, Martin Varga

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Biochemical and Physiological Effects of Galanin in Health and Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sara HuberResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Theresia FitznerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
René G FeichtingerDepartment of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-4215-8258
Sarah HochmannCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Theo KrausDepartment of Pathology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0003-2944-5129
Karl SotlarDepartment of Pathology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Barbara KoflerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-1198-4776
Martin VargaDepartment of Surgery, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Paracelsus Medical University · AT

Funding

Land Salzburg WISS 2025 F 2000237-FIP "STEBS".Paracelsus Medical University R20/01/128-VAM
6 · The paper itself

Abstract

backgroundPerihilar cholangiocarcinoma (pCCA) is characterised by poor outcomes. Early diagnosis is essential for patient survival. The peptide galanin (GAL) and its receptors GAL

methodsImmunohistochemical staining was performed in healthy controls (

resultsGAL and GAL

conclusionsOur in-depth characterisation of the GAL system in the healthy human biliary duct and pCCA in a small patient cohort revealed that GAL and GAL

Indexed as

Bile Duct NeoplasmsCholestasisKlatskin TumorPeptide HormonesBile DuctsGalaninHumansGalaninPeptide Hormonesbile ductcholangiocarcinomacholangiocytescholestasisgalaningalanin receptorpeptide

Identifiers

PMID37443714
PMCPMC10340323
OpenAlexW4381617702

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.